Literature DB >> 10919032

HCV infection in the general population of a Greek island: prevalence and risk factors.

C Goritsas1, I Plerou, S Agaliotis, R Spinthaki, K Mimidis, D Velissaris, N Lazarou, C Labropoulou-Karatza.   

Abstract

BACKGROUND/AIMS: Although HCV seroprevalence in blood donors in Greece is low (0.2-0.4%) epidemiologic characteristics of HCV infection in the general population have not been studied enough. The objective of this study was to examine the seroprevalence of HCV infection and associated risk factors in the general population of Zakinthos, a Greek island with a well-defined mixed (urban and rural) population.
METHODOLOGY: A household health survey was carried out in a randomly selected sample of 718 adults. A questionnaire was completed and a blood sample was obtained from all participants. Serum samples were tested for anti-HCV antibodies by third generation enzyme-linked immunosorbent assay and supplemental test. The influence of sociodemographic characteristics and possible associated risk factors on the HCV seroprevalence was investigated by logistic regression analysis.
RESULTS: The overall anti-HCV prevalence was 1.25%. A well-defined rural area with a significant higher prevalence (6.8% vs. 0.62%; P < 0.001) was identified. There was a trend of increasing prevalence with age, with a significant difference (P < 0.027) between the age groups 15-44 (0%) and over 45 (2.15%). The logistic regression analysis confirmed a significant association between anti- HCV positivity and: increasing age (P < 0.001), history of blood transfusion (0.0001), intramuscular injections (P < 0.04).
CONCLUSIONS: The results of this field-survey in a well-defined general population, indicates that HCV seroprevalence (1.25%) is much higher than that of blood donors in the same area. The increasing prevalence with age and the association with parenteral exposure indicates that HCV infection can mainly be attributed to parenteral techniques in the past. The identification of a concrete rural area with particularly high seroprevalence needs further study of the whole population of the area.

Entities:  

Mesh:

Year:  2000        PMID: 10919032

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  13 in total

1.  Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study.

Authors:  M Raptopoulou; G Touloumi; D Tzourmakliotis; G Nikolopoulou; M Dimopoulou; G Giannoulis; T Vasiliadis; A Skoutelis; O Anagnostou; G Hatzis; S Manolakopoulos
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

2.  Prevalence of hepatitis B and C markers among refugees in Athens.

Authors:  Anastasios Roussos; Constantin Goritsas; Thomas Pappas; Maria Spanaki; Panagiota Papadaki; Angeliki Ferti
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

Review 3.  Hepatitis C virus and type 2 diabetes.

Authors:  Francesco Negro; Mahnaz Alaei
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

4.  Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees.

Authors:  V Sypsa; E Hadjipaschali; A Hatzakis
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

5.  Hepatitis C Virus infections trends in Italy, 1996-2006.

Authors:  Giuseppe La Torre; Maria Rosaria Gualano; Leda Semyonov; Nicola Nicolotti; Walter Ricciardi; Antonio Boccia
Journal:  Hepat Mon       Date:  2011-11-30       Impact factor: 0.660

6.  Prevalence of chronic hepatitis B and hepatitis C among first time blood donors in Northeast Bosnia and Herzegovina: an estimate of prevalence in general population.

Authors:  Jasminka Petrovic; Nermin N Salkic; Sead Ahmetagic; Vildana Stojic; Slavica Mott-Divkovic
Journal:  Hepat Mon       Date:  2011-08       Impact factor: 0.660

7.  Seroprevalence of anti-HCV antibodies among blood donors of north India.

Authors:  R N Makroo; Rimpreet Singh Walia; Mohit Chowdhry; Aakanksha Bhatia; Vikas Hegde; N L Rosamma
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

8.  Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics.

Authors:  Gkikas Magiorkinis; Vana Sypsa; Emmanouil Magiorkinis; Dimitrios Paraskevis; Antigoni Katsoulidou; Robert Belshaw; Christophe Fraser; Oliver George Pybus; Angelos Hatzakis
Journal:  PLoS Comput Biol       Date:  2013-01-31       Impact factor: 4.475

Review 9.  Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.

Authors:  Susan J M Hahné; Irene K Veldhuijzen; Lucas Wiessing; Tek-Ang Lim; Mika Salminen; Marita van de Laar
Journal:  BMC Infect Dis       Date:  2013-04-18       Impact factor: 3.090

10.  Hepatitis B and C virus prevalence in a rural area of South Korea: the role of acupuncture.

Authors:  H R Shin; J Y Kim; J I Kim; D H Lee; K Y Yoo; D S Lee; S Franceschi
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.